Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies.
about
Bioinformatic analysis of HIV-1 entry and pathogenesis.Characterization of partial and near full-length genomes of HIV-1 strains sampled from recently infected individuals in São Paulo, BrazilHigh proportion of HIV serodiscordance among HIV-affected married couples in northern VietnamReliable genotypic tropism tests for the major HIV-1 subtypesSensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.Limited evolution of inferred HIV-1 tropism while viremia is undetectable during standard HAART therapyGenotypic tropism testing by massively parallel sequencing: qualitative and quantitative analysis.Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use.A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individualsSingle genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope.Association between HIV-1 tropism and CCR5 human haplotype E in a Caucasian population.Geno2pheno[454]: a Web server for the prediction of HIV-1 coreceptor usage from next-generation sequencing data.Faster HIV-1 disease progression among Brazilian individuals recently infected with CXCR4-utilizing strainsAppraising the performance of genotyping tools in the prediction of coreceptor tropism in HIV-1 subtype C virusesA genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patientsHIV-1 tropism: a comparison between RNA and proviral DNA in routine clinical samples from Chilean patientsHigh prevalence of CXCR4 usage among treatment-naive CRF01_AE and CRF51_01B-infected HIV-1 subjects in Singapore.Complexity and dynamics of HIV-1 chemokine receptor usage in a multidrug-resistant adolescentVariability of HIV-1 genomes among children and adolescents from São Paulo, BrazilA case-based reasoning system for genotypic prediction of HIV-1 co-receptor tropism.HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalization.A diagnostic HIV-1 tropism system based on sequence relatedness.Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropism.HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less-efficient mechanism of gp120-CCR5 engagement that attenuates macrophage tropismCovariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithms.Impact of mutations outside the V3 region on coreceptor tropism phenotypically assessed in patients infected with HIV-1 subtype BCorrelation of the virological response to short-term maraviroc monotherapy with standard and deep-sequencing-based genotypic tropism prediction methods.The epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South Africa.Impact of baseline HIV-1 tropism on viral response and CD4 cell count gains in HIV-infected patients receiving first-line antiretroviral therapy.Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.The temporal increase in HIV-1 non-R5 tropism frequency among newly diagnosed patients from northern Poland is associated with clustered transmissions.Concordance of HIV type 1 tropism phenotype to predictions using web-based analysis of V3 sequences: composite algorithms may be needed to properly assess viral tropismA novel denaturing heteroduplex tracking assay for genotypic prediction of HIV-1 tropism.Frequency and predictors of HIV-1 co-receptor switch in treatment naive patientsGenotypic analysis of the V3 region of HIV from virologic nonresponders to maraviroc-containing regimens reveals distinct patterns of failure.Virological and immunological response to antiretroviral regimens containing maraviroc in HIV type 1-infected patients in clinical practice: role of different tropism testing results and of concomitant treatments.HIV-1 tropism testing and clinical management of CCR5 antagonists: Quebec review and recommendations.Comparison of genotypic and phenotypic HIV type 1 tropism assay: results from the screening samples of Cenicriviroc Study 202, a randomized phase II trial in treatment-naive subjects.Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy.CCR5 inhibitors: emergence, success, and challenges.
P2860
Q27693321-69395C62-A2B0-40AF-96F7-81A7F529C1A5Q28477491-96886763-0D15-498F-BBD0-36D94B7F0423Q28546629-23DEBC11-7390-4958-8F50-C1FF83365236Q30372085-7AFCB6CC-F2B4-4A67-A08F-6A7870649FADQ33622927-7A7ED9C8-9ADB-4126-BCEF-EF4E2C59EA5AQ33721466-7AB5BFEC-CA3A-4520-9EC5-66449B47D48AQ33899080-C9C53092-DFC4-4EC0-AB46-39E032F6588BQ33961704-16F2CE1B-B0EE-40D8-B1AA-9DDE249766D0Q34009093-76B2203F-F154-4154-A10B-8ED6D31E41A5Q34091371-9534612B-4E43-4674-826F-1488B34B883EQ34098010-D44C4D2C-D1ED-4AA6-9805-F969BB09276DQ34144135-3853C7F0-3826-425C-9004-4B61D359EDC9Q34145972-2A6C89E9-51BD-4704-BD17-E191FA7414D1Q34400487-F378D3B0-C9DC-44F1-A9FE-3CB1140D6BAAQ34431102-BB474385-4CC4-4691-8AB9-983A3633091FQ34508492-9D3B3B1B-5EC2-41CE-B486-CC487FE00A29Q34591699-1F5E695A-20BB-405F-B7AA-B0D6D7BEB1F7Q34606488-FF6AE2F7-E6E1-4B1F-8A09-AF83E7D4839AQ34717313-944DFE92-7450-404B-B7EB-6DA26B9E7C5DQ34823507-3BC65586-88ED-403A-8D30-ABBC25D37B1BQ34923915-5D53F368-BA7C-4917-8538-647710EBEE16Q34983107-63ECDB0A-FBED-4254-9405-32173BE3F9FFQ35004817-093C6101-5372-4D88-BF45-2506EF0FF4F2Q35076868-7338708A-B11A-4EDA-ACDE-D88C67920B63Q35330357-6E41BAD4-6438-48FF-8236-D6D8F01E9497Q35364051-FE891C33-3A49-4842-AB32-3D75E5BF0B8AQ35806266-87600157-BC3F-459D-B4B4-63A971ED3AAEQ35818419-CF255BB8-8B6E-478F-9E6D-B3CAB3EBDAA5Q35838609-EA2F8251-493B-4809-BA0D-F8AFA9BC1348Q35953203-66DB2E47-BC87-49BE-8CAD-C78754BAF73DQ35983415-14806A5A-C0A0-4E92-B5CC-27B7669A2578Q36050112-EFFC1A57-F2B0-4224-A0A9-17509B685B3DQ36157741-165695AD-4A8C-46FF-8192-1C0B93CF6A24Q37288573-3137D8B0-43CD-49E8-9574-397DCB370546Q37335890-75F08B08-E7BD-4E97-AE4C-740061E816C3Q37460123-8FD9B599-4A7B-4C83-BC55-14C3C8F34635Q37525642-4F3A2F54-8458-4438-9D23-AE3F27008DE5Q37547823-5F7CB168-42D0-48D4-B894-513DD2B1BCF7Q37637067-66D293E4-B44C-4DC4-ADF3-1BE5CC8CA1F9Q38005459-700C642D-4F1C-45B4-BD7A-4D97D6503E03
P2860
Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Population-based V3 genotypic ...... A4001029 and MOTIVATE studies.
@en
Population-based V3 genotypic ...... A4001029 and MOTIVATE studies.
@nl
type
label
Population-based V3 genotypic ...... A4001029 and MOTIVATE studies.
@en
Population-based V3 genotypic ...... A4001029 and MOTIVATE studies.
@nl
prefLabel
Population-based V3 genotypic ...... A4001029 and MOTIVATE studies.
@en
Population-based V3 genotypic ...... A4001029 and MOTIVATE studies.
@nl
P2093
P1433
P1476
Population-based V3 genotypic ...... A4001029 and MOTIVATE studies.
@en
P2093
Alexander Thielen
Conan K Woods
Douglass Chapman
Hernan Valdez
Jayvant Heera
Marilyn Lewis
P Richard Harrigan
Rachel A McGovern
Theresa Mo
P304
P356
10.1097/QAD.0B013E32833E6CFB
P407
P577
2010-10-01T00:00:00Z